Morning Break: 23andMe Under Scrutiny; Work Wellness Flops; Fentanyl a WMD?

Note that some links may require subscriptions.

New research finds that 23andMe’s BRCA1/2 test may be unreliable for detecting breast and ovarian cancer susceptibility. (New York Times)

Stanford cleared its professors of wrongdoing over their correspondence with the Chinese scientist involved in gene-edited babies. (Stanford Daily)

The U.S. Preventive Services Task Force says there is insufficient evidence that screening for elevated blood lead levels benefits asymptomatic children and pregnant women, echoing a draft report last fall. (JAMA, MedPage Today)

“There is no quick way out of this vaccine-hesitant moment.” — One pediatrician’s take on why some parents don’t trust vaccines. (Huffington Post)

A New York man may have exported the state’s measles outbreak to Michigan, while Rockland County, New York, health officials take new actions (fines, strongly worded letters) to stop the disease’s spread. (CBS News)

Republicans are rejecting state-level bills aiming to close childhood immunization loopholes. (Politico)

But the push for so-called heartbeat abortion bills are losing steam due to concerns over potentially costly legal battles. (Kaiser Health News)

Government reforms in Mexico are jeopardizing HIV treatment and prevention programs, critics say. (Reuters)

Cluster-randomized trial has bad news for advocates of workplace wellness programs. (CNBC)

Cholera on the rise in Nairobi, Kenya, with hospital workers among those affected. (Reuters)

Pop/R&B singer Bebe Rexha goes public with her bipolar disorder diagnosis in a series of tweets. (NBC News)

FDA cleared a weight-management device dubbed Plenity, a capsule containing hydrogel particles that take up space in the stomach and create a sense of fullness. (The Hill)

FDA again warns companies and consumers about “unlawful ingredients” included in dietary supplements.

The Department of Homeland Security may classify fentanyl as a “weapon of mass destruction.” (Gizmodo)

Morning Break is a daily guide to what’s new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com

2019-04-17T09:00:00-0400